<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        6-328-19
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ZALDIAR
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        TRAMADOL HYDROCHLORIDE,PARACETAMOL
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        325,37.5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Controlled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        27.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="FARMACEUTICI FORMENTI" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            FARMACEUTICI FORMENTI
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 392]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            AL-KAMAL IMPORT OFFICE CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            STADA ARZNEIMITTEL GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        N02AX52
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ZALDIAR is a combination of two analgesics, tramadol and paracetamol, which act together to relieve your pain.</p><p>ZALDIAR is intended for use in the treatment of moderate to severe pain when your doctor recommends that a combination of tramadol and paracetamol is needed.</p><p>ZALDIAR should only be taken by adults and adolescents over 12 years.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take ZALDIAR</p><p>- if you have had an allergic reaction (for instance skin rash, swelling of the face, wheezing or difficulty breathing) after taking tramadol or paracetamol or any of the other ingredients in ZALDIAR;</p><p>- in acute poisoning with alcohol, sleeping pills, pain relievers or other psychotropic medicines (medicines that affect mood and emotions);</p><p>- if you are also taking MAO inhibitors (certain medicines used for treatment of depression or Parkinson&rsquo;s disease) or have taken them in the last 14 days before treatment with ZALDIAR;</p><p>- if you suffer from a severe liver disorder;</p><p>- if you have epilepsy that is not adequately controlled on your current medicine.</p><p><strong>Take special care with ZALDIAR if you</strong></p><p><strong>- </strong>take other medicines containing paracetamol or tramadol;</p><p>- have liver problems or liver disease or if you notice your eyes and skin turning yellow. This may suggest jaundice or problems with your bile ducts.</p><p>- have kidney problems;</p><p>- have severe difficulties in breathing for example asthma or severe lung problems;</p><p>- have epilepsy or have already experienced fits or seizures;</p><p>- have recently suffered from a head injury, shock or severe headaches associated with vomiting;</p><p>- are dependent on any medicines including those used to relieve pain, for example morphine;</p><p>- take other medicines to treat pain that contain buprenorphine, nalbuphine or pentazocine;</p><p>- are going to have an anaesthetic. Tell your doctor or dentist that you are taking ZALDIAR.</p><p>If any of the above-mentioned points applied to you in the past or applies to you while you are taking ZALDIAR, please make sure your doctor knows. He/she can then decide whether you should continue to use this medicine.</p><p>Tramadol is transformed in the liver by an enzyme. Some people have a variation of this enzyme and this can affect people in different ways. In some people, they may not get enough pain relief but other people are more likely to get serious side effects</p><p>If you notice any of the following side effects, you must stop taking this medicine and seek immediate medical advice:</p><p>slow or shallow breathing, confusion, sleepiness, small pupils, feeling or being sick, constipation, lack of appetite.</p><p><strong>Taking other medicines</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including<strong> </strong>medicines obtained without a prescription.</p><p><strong>Important: This medicine contains paracetamol and tramadol. Tell your doctor if you are taking any other medicine containing paracetamol or tramadol, so that you do not exceed the maximum daily doses.</strong></p><p>You must not take ZALDIAR together with monoamine oxidase inhibitors (&ldquo;MAOIs&rdquo;) (see section &ldquo;Do not take ZALDIAR&rdquo;).</p><p>ZALDIAR is not recommended to be taken with the following:</p><p>- carbamazepine (a medicine commonly used to treat epilepsy or some types of pain such as severe pain attacks in the face called trigeminal neuralgia).</p><p>- buprenorphine, nalbuphine or pentazocine (opioid-type pain relievers). The pain-relieving effect may be reduced.</p><p><strong><u>The risk of side effects increases, if you also take</u></strong></p><p>- triptans (for migraine) or selective serotonin re-uptake inhibitors, &ldquo;SSRIs&rdquo; (for depression). If you experience confusion, restlessness, fever, sweating, uncoordinated movement of limbs or eyes, uncontrollable jerking of muscles or diarrhoea you should call your doctor.</p><p>- tranquillizers, sleeping pills, other pain relievers such as morphine and codeine (also as cough medicine), baclofen (a muscle relaxant), medicines used to lower blood pressure, antidepressants or medicines to treat allergies. You may feel drowsy or feel faint. If this happens, tell your doctor.</p><p>- antidepressants, anaesthetics, neuroleptics (medicines that affect the state of mind) or bupropion (to help stop smoking). The risk having a fit may increase. Your doctor will tell you whether ZALDIAR is suitable for you.</p><p>- warfarin or phenprocoumon (for blood thinning). The effectiveness of such medicines may be altered and bleeding may occur. Any prolonged or unexpected bleeding should be reported to your doctor immediately.</p><p><u>The effectiveness of ZALDIAR may be altered if you also take</u></p><p>- metoclopramide, domperidone or ondansetron (medicines for treatment of nausea and vomiting),</p><p>- cholestyramine (medicine to reduce cholesterol in the blood),</p><p>- ketoconazole or erythromycin (medicines against infections).</p><p>Your doctor will tell you which medicines are safe to take with ZALDIAR.</p><p><strong>Taking ZALDIAR with food and drink</strong></p><p>ZALDIAR may make you feel drowsy. Alcohol may make you feel more drowsy, so it is best not to drink alcohol while you are taking ZALDIAR.</p><p><strong>Pregnancy and breast-feeding</strong></p><p><strong>As ZALDIAR</strong> contains tramadol, you should not take this medicine during pregnancy. If you become pregnant during treatment with ZALDIAR, please consult your doctor before taking any further tablets. Small amounts of tramadol may pass into the breast-milk. Therefore you should not take this medicine during breast-feeding.</p><p>Tramadol is excreted into breast milk. For this reason, you should not take ZALIDAR more than once during breast-feeding, or alternatively, if you take ZALIDAR more than once, you should stop breast-feeding.</p><p><strong>Driving and using machines</strong></p><p>ZALDIAR may make you feel drowsy and this may affect your ability to drive, or use tools and machines, safely.</p><p><strong>Important information about some of the ingredients of Zaldiar</strong></p><p>Lactose is an ingredient in these tablets. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take ZALDIAR exactly as your doctor has told you. You should check with your doctor or pharmacist if<strong> </strong>you are not sure.</p><p>You should take ZALDIAR for as short a time as possible.</p><p><strong>Children and adolescents</strong></p><p>Use in children with breathing problems:</p><p>Tramadol is not recommended in children with breathing problems, since the symptoms of tramadol toxicity may be worse in these children.</p><p>The use in children below the age of 12 years is not recommended.</p><p>Unless otherwise prescribed by your doctor, the usual starting dose for adults and adolescents over 12 years is 2 tablets.</p><p>If required, further doses may be taken, as recommended by your doctor. The shortest time between doses must be at least 6 hours.</p><p><strong>Do not take more than 8 ZALDIAR film-coated tablets per day.</strong></p><p>Do not take ZALDIAR more often than your doctor has told you.</p><p>Your doctor may increase the time between doses</p><p><strong>- </strong>if you are older than 75 years,</p><p>- if you have kidney problems or</p><p>- if you have liver problems.</p><p><strong>Method of administration:</strong></p><p>The tablets are for oral use.</p><p>Swallow the tablets whole with sufficient liquid. They should not be broken or chewed.</p><p>If you think that the effect of ZALDIAR is too strong (i.e. you feel very drowsy or have difficulty breathing) or too weak (i.e. you have inadequate pain relief), contact your doctor.</p><p><strong>If you take more ZALDIAR than you should:</strong></p><p>In such cases please contact your doctor or pharmacist immediately even if you feel well. There is a risk of liver damage which may only show later.</p><p><strong>If you forget to take ZALDIAR:</strong></p><p>If you forget to take the tablets, pain is likely to return. Do not take a double dose to make up for forgotten<strong> </strong>individual doses, simply continue taking the tablets as before.</p><p><strong>If you stop taking ZALDIAR:</strong></p><p>Generally there will be no after-effects when treatment with ZALDIAR is stopped. However, on rare occasions,<strong> </strong>people who have been taking tramadol for some time may feel unwell if they stop treatment abruptly (see section 4. &ldquo;Possible Side Effects&rdquo;). If you have been taking ZALDIAR for some time, you should talk to your doctor if you want to stop because your body may have become used to it.</p><p>You should not suddenly stop taking this medicine unless your doctor tells you to. If you want to stop taking your medicine, discuss this with your doctor first, particularly if you have been taking it for a long time. Your doctor will advise you when and how to stop, which may be by lowering the dose gradually to reduce the chance of developing unnecessary side effects (withdrawal symptoms).</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>THIS IS A MEDICAMENT</strong></p><p><strong>- </strong>Medicament is a product, which affects your health and its consumption contrary to instructions is dangerous for you.</p><p>- Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.</p><p>- The doctor and the pharmacist are the experts in medicines, their benefits and risks.</p><p>- Do not by yourself interrupt the period of treatment prescribed for you.</p><p>- Do not repeat the same prescription without consulting your doctor.</p><p>Keep all medicaments out of reach of children.</p><p>Council of Arab Health Ministers,</p><p>Union of Arab Pharmacists</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, ZALDIAR can cause side effects, although not everybody gets them.</p><p><u>Very common:</u> more than 1 out of 10 persons treated;</p><p>- nausea,</p><p>- dizziness, drowsiness.</p><p><u>Common:</u> less than 1 out of 10, but more than 1 out of 100 persons treated;</p><p>- vomiting, digestion problems (constipation, flatulence, diarrhoea), stomach pain, dry mouth,</p><p>- itching, sweating,</p><p>- headache, shaking,</p><p>- confusion, sleep disorders, mood changes (anxiety, nervousness, a feeling of high spirits).</p><p><u>Uncommon:</u> less than 1 out of 100, but more than 1 out of 1,000 persons treated;</p><p>- increase in pulse or blood pressure , heart rate or heart rhythm disorders,</p><p>- difficulty or pain on passing water,</p><p>- skin reactions (for example rashes, hives),</p><p>- tingling, numbness or feeling of pins and needles in the limbs, ringing in the ear, involuntary muscle twitching,</p><p>- depression, nightmares, hallucinations (hearing, seeing or sensing things that are not really there), memory lapses,</p><p>- difficulty swallowing, blood in the stools,</p><p>- shivering, hot flushes, pain in the chest,</p><p>- difficulty breathing.</p><p><u>Rare:</u> less than 1 out of 1,000, but more than 1 out of 10,000 persons treated;</p><p>- fits, difficulties in carrying out coordinated movements,</p><p>- addiction,</p><p>- blurred vision.</p><p>The following are recognised side effects which have been reported by people using medicines that contain only tramadol or only paracetamol. However, if you experience any of these while taking ZALDIAR, you should tell your doctor:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; feeling faint when getting up from a lying or sitting position, slow heart rate, fainting, changes in appetite, muscle weakness, slower or weaker breathing, mood changes, changes in activity, changes in perception, worsening of existing asthma.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In some rare cases a skin rash, indicating an allergic reaction, may develop with sudden swelling of the face and neck, difficulties breathing or drop of blood pressure and fainting. If this happens to you, <u>stop treatment and see a doctor immediately. You must not take the medicine again.</u></p><p>In rare cases, using a medicine of the type of tramadol may make you become dependent on it, making it hard<u> </u>to stop taking it.</p><p>On rare occasions, people who have been taking tramadol for some time may feel unwell if they stop treatment abruptly. They may feel agitated, anxious, nervous or shaky. They may be hyperactive, have difficulty sleeping and have stomach or bowel disorders. Very few people may also get panic attacks, hallucinations, unusual perceptions such as itching, tingling and numbness, and noise in the ears (tinnitus). If you experience any of these complaints after stopping ZALDIAR, please consult your doctor.</p><p>In exceptional cases blood tests may reveal certain abnormalities, for instance, low counts of blood platelets, which may result in nose bleeds or bleeding gums.</p><p>Use of ZALDIAR together with medicines used to thin the blood (e.g. phenprocoumon, warfarin) may increase the bleeding risk. Any prolonged or unexpected bleeding should be reported to your doctor immediately.</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>Keep out of the reach and sight of children.</p><p>Do not use the ZALDIAR after the expiry date which is printed on the carton and the edge of the blister after</p><p>[EXP.:]. The expiry date refers to the last day of that month.</p><p>Do not store above 30˚C.</p><p>Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>- </strong>The active substances are tramadol hydrochloride and paracetamol.</p><p>One film-coated tablet contains 37.5 mg tramadol hydrochloride and 325 mg paracetamol.</p><p><strong>- </strong>The other ingredients are:</p><p><u>Tablet core:</u> powdered cellulose; pregelatinised starch; sodium starch glycolate (type A); maize starch; magnesium stearate.</p><p><u>Film-coating:</u> hypromellose; lactose monohydrate; titanium dioxide (E 171); macrogol 6000; yellow iron oxide (E 172); propylene glycol; talc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ZALDIAR film-coated tablets are pale yellow film-coated tablets, marked with the logo on one side, marked “T5” on the other side.
ZALDIAR film-coated tablets are packed in blister strips. ZALDIAR comes in cartons of 10 and 20 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation holder and responsible for batch release:</strong></p><p>STADA Arzneimittel AG</p><p>Stadastrasse 2-18</p><p>61118 Bad Vilbel</p><p>Germany</p><p><strong>Bulk Manufacturer:</strong></p><p>Farmaceutici Formenti S.p.A.</p><p>Via di Vittorio 2</p><p>21040 Origgio (VA)</p><p>Italy</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                April 2014.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">إن زلديار هو مستحضر مركب من مادتين مسكنتين للألم وهما ترامادول وباراسيتامول وتعمل المادتين معًا لتسكين الأم.</p><p dir="RTL">يستعمل زلديار في معالجة الآلام من المتوسطة إلى الحادة عندما ينصحك الطبيب بأنك تحتاج إلى استعمال مستحضر مركب من الترامادول والباراسيتامول.</p><p dir="RTL">يؤخذ زلديار فقط من قبل البالغين والمراهقين من سن ۱۲ عامًا فما فوق.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تأخذ زلديار</strong></p><p dir="RTL">- إذا أصبت برد فعل أرجی (كالطفح الجلدي على سبيل المثال. أو انتفاخ الوجه، أو أزيز تنفسي أو صعوبة في التنفس) بعد أخذ ترامادول أو باراسيتامول أو أي من المكونات الأخرى التي يحتوي عليها زلديار.</p><p dir="RTL">- عند التسمم الحاد بالكحول، أو أقراص النوم، أو مسكنات الألم، أو غيرها من العقاقير النفسية (الأدوية التي</p><p dir="RTL">تؤثر على المزاج والعواطف).</p><p dir="RTL">- إذا كنت تأخذ في نفس الوقت مثبطات أكسيداز أحادي الأمين MAO (ادوية معينة تستعمل في معالجة الاكتئاب أو مرض باركنسون) أو إذا كنت تأخذها في آخر 14 يومًا قبل المعالجة بمستحضر زلديار.</p><p dir="RTL">- إذا كنت تعاني من اضطراب کبدي خطير.</p><p dir="RTL">- إذا كنت مصابًا بالصرع الذي لا يمكن التحكم به بشكل سليم وواف عن طريق الدواء الذي تأخذه حاليًا.</p><p dir="RTL"><strong>يتوجب عليك توخي الحذر الخاص في الحالات التالية مع زلديار</strong></p><p dir="RTL">- إذا كنت تأخذ أدوية أخرى تحتوي على باراسيتامول أو ترامادول</p><p dir="RTL">- إذا كنت تعاني من مشاكل كبدية أو مرض کبدي أو إذا لاحظت بأن لون عينيك وجلدك تحول إلى الأصفر. قد يكون ذلك دليلًا على إصابتك باليرقان أو مشاكل في قنوات الصفراء</p><p dir="RTL">- إذا كنت مصابة بمشاكل كلوية.</p><p dir="RTL">- إذا كنت تعاني من صعوبات شديدة في التنفس كالربو على سبيل المثال أو مشاكل رئوية شديدة</p><p dir="RTL">- إذا كنت مصابة بالصرع أو سبق وأن أصبت بالنويات</p><p dir="RTL">- &nbsp;إذا تعرضت لإصابة في الرأس قبل فترة وجيزة أو صدمة أو صداع شديد يصاحبه تقيؤ.</p><p dir="RTL">- إذا كنت معتمدة على أية أدوية بما فيها تلك المستخدمة في تسكين الألم مثل المورفين.</p><p dir="RTL">- إذا كنت تأخذ أدوية أخرى معالجة الألم تحتوى على بوبرينورفين أو تالبوقين أو بنتازوسین</p><p dir="RTL">- إذا كنت ستحصل على تخدير يجب عليك إعلام الطبيب أو طبيب الأسنان بأنك تأخذ زلديار</p><p dir="RTL">إذا انطبقت عليك إحدى النقاط المذكورة أعلاه في السابق أو إذا كانت تنطبق عليك حاليا أثناء أخذك زلديار يرجى التأكد من إعلام طبيبك كي يقرر فيما إذا جاز مواصلة استعمال هذا الدواء</p><p dir="RTL">يتحول الترامادول في الكبد بفعل إنزيم معين، وبعض الأشخاص يكون لديهم شكل مختلف من هذا الانزيم، وهو ما يمكن أن يؤدي إلى آثار مختلفة للدواء، ففي بعض الأحيان، قد لا يشعر المريض براحة كافية؛ بل إن بعض الأشخاص قد يصابون بأعراض جانبية خطيرة.</p><p dir="RTL">فإذا لاحظت أيًا من الأعراض الجانبية التالية، فيجب عليك التوقف عن تناول هذا الدواء وطلب الاستشارة الطبية على الفور:</p><p dir="RTL">بط، أو سرعة التنفس، التشوش، النعاس، صغر بؤبؤ العين، الشعور أو الإصابة بالإعياء، الإمساك، فقدان الشهية</p><p dir="RTL"><strong>أخذ أدوية أخرى:</strong></p><p dir="RTL">يرجى إعلام الطبيب أو الصيدلاني إذا كنت تأخذ حاليا أدوية أخرى أو إذا تناولتها حديثًا أو مؤخرًا حتى إذا لم تتطلب هذه الأدوية إعطاء وصفة طبية لها.</p><p dir="RTL"><strong>هام يحتوي هذا الدواء على المادتين باراسيتامول وترامادول من أجل عدم تجاوز الجرعة اليومية القصوى لهائين المادتين يجب عليك إعلام طبيبك إذا كنت تأخذ أي دواء آخر يحتوي على باراسيتامول أو ترامادول.</strong></p><p dir="RTL">لا يجوز لك أخذ زلديار مع مثبطات أكسيداز أحادي الأمين (MAOI) (انظر فقرة &quot;لا تأخذ الديار&quot;).</p><p dir="RTL"><strong><u>لا يوصى أخذ الديار مع المواد التالية:</u></strong></p><p dir="RTL">- کاربامازيبين (دواء يستعمل على نحو شائع في معالجة الصرع أو بعض أنواع الألم مثل نوبات الألم الحادة في الوجه</p><p dir="RTL">والتي تدعي بألم العصب المثلث التوائم)</p><p dir="RTL">- بوپرنورفین أو ناليوفين أو بنتازوسين (مسكنات أفيونية النوع)، فقد يتم اضعاف المفعول المسكن للألم.</p><p dir="RTL"><strong><u>تزداد مخاطر حدوث الأعراض الجانبية إذا اخذت المواد التالية في نفس الوقت:</u></strong></p><p dir="RTL">- التريبتانات (لمعالجة الشقيقة أو مثبطات أو إعادة قبط السيروتونين الانتقائية &quot;SSRI&#39; (لمعالجة الإكتئاب) إذا أصبت بالارتباك، أو التململ، أو الحمى، أو التعرق، أو عدم التناسق الحركي في الأطراف والعينين، أو الانتفاضات العضلية غير المتحكم بها، أو الاسهال ينبغي عليك مراجعة طبيبك.</p><p dir="RTL">- المهدئات بو أقراص النوم وبعض أنواع مسكنات الأمم الأخرى على غرار المورفين والكودين (أيضا كدواء لمعالجة</p><p dir="RTL">السعال) أو باكلوفين (مرخي عضلي)، أو الأدوية المستعملة في تخفيض ضغط الدم، أو مضادات الاكتئاب، أو الأدوية المستعملة في معالجة الأرجات. وقد تشعر بالنعاس أو بأنه سيغمي عليك. فاذا حدث ذلك يجب عليك ابلاغ طبيبك.</p><p dir="RTL">- مضادات الاكتئاب، أو أدوية التخدير، أو المهدئات العصبية (أدوية تؤثر على حالة العقل) أو بوپروپیون (يساعدك</p><p dir="RTL">على التوقف عن التدخين). وقد تزداد مخاطر حدوث النوبات. سيخبرك طبيبك فيما إذا كان الدیار مناسبا لك.</p><p dir="RTL">- وارفارین او فنبروكومون (التمييع الدم) وقد يتم تغيير فعالية هذه الأدوية مع إمكانية حدوث النزيف فاذا حدث أي نزيف طويل أو غير متوقع يجب عليك ابلاغ طبيبك على الفور.</p><p dir="RTL">فقد يتم تغيير فعالية الديار إذا أخذت الأدوية التالية في نفس الوقت:</p><p dir="RTL">- ميتوكلوبراميد أو دومبريدون أو أندانسیترون (أدوية تستعمل في معالجة الغثيان والتقيؤ).</p><p dir="RTL">- کولستيرامين (دواء لتخفيض الكولسترول في الدم)</p><p dir="RTL">- کینوکونازول أو إريثروميسين ( أدوية ضد الأخماج).</p><p dir="RTL">وسيخبرك طبيبك أية أدوية تكون أمنة الاستعمال مع زلديار.</p><p dir="RTL"><strong>أخذ زلديار مع الأطعمة والمشروبات</strong></p><p dir="RTL">زلديار قد يجعلك تشعر بالنعاس، الكحول قد يسبب لك المزيد من النعاس ولذلك فإنه يستحسن عدم تناول الكحول أثناء أخذك مستحضر زلديار.</p><p dir="RTL"><strong>الحمل والارضاع</strong></p><p dir="RTL"><strong>أن زلديار يحتوي على ترامادول وبالتالي فانه ينبغي عليك عدم أخذ هذا الدواء خلال الحمل، اما إذا أصبحت حاملا أثناء العلاج بمستحضر زلديار، عندها يرجى استشارة الطبيب قبل مواصلة أخذ أية أقراص أخرى.</strong></p><p dir="RTL">يتم إفراز الترامادول في حليب الثدي، ولهذا السبب، يجب عليك عدم تناول الديار أكثر من مرة واحدة خلال فترة الرضاعة الطبيعية، أو التوقف عن الرضاعة الطبيعية عند تناول زلديار أكثر من مرة.</p><p dir="RTL">قد يدخل ترامادول في حليب الأم بكميات ضئيلة، وبالتالي فإنه ينبغي عليك عدم اخذ هذا الدواء خلال الإرضاع.</p><p dir="RTL">القيادة وتشغيل الماكينات والأجهزة:</p><p dir="RTL">قد يسبب لك الديار النعاس مما قد يؤثر على قدرتك على القيادة واستعمال العدة وتشغيل الماكينات بأمان وسلامة</p><p dir="RTL">معلومات هامة حول بعض العناصر التي يحتوي عليها زلديار</p><p dir="RTL">تحتوي الأقراص على اللاكتوز</p><p dir="RTL">فاذا أخبرك طبيبك بانك تعاني من عدم تحمل لبعض أنواع السكر يجب عليك مراجعته قبل اخذ هذا المنتج الطبي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يجب عليك دائما أخذ زلديار بالضبط وفقا لإرشادات طبيبك. يرجى استشارة الطبيب أو الصيدلاني إذا لم تكن متأكدًا.</p><p dir="RTL">ينبغي عليك أخذ زلديار على مدي أقصر فترة ممكنة.</p><p dir="RTL"><strong><u>الأطفال والمراهقون</u></strong></p><p dir="RTL">الاستخدام مع الأطفال الذين يعانون من صعوبات في التنفس:</p><p dir="RTL">لا يوصى باستخدام الترامادول مع الأطفال الذين يعانون من صعوبات في التنفس، حيث إن أعراض التسمم بالترامادول قد تكون أكثر خطورة لدى هؤلاء الأطفال</p><p dir="RTL">لا يوصي باستعمال المستحضر عند الاطفال دون سن ۱۲ عام.</p><p dir="RTL">ما لم يوصي الطبيب بغير ذلك فإن جرعة البداية المعتادة للبالغين والمراهقين فوق ۱۲ عاما تبلغ قرصين اثنين</p><p dir="RTL">عند الحاجة يجوز أخذ المزيد من الجرعات إذا أوصى طبيبك بذلك. ويجب ان يكون هنالك فاصلا زمنيًا بالغا 6 ساعات على الأقل بين الجرعات</p><p dir="RTL"><strong>لا تأخذ أكثر من 8 أقراص مغلفة زلديار في اليوم</strong></p><p dir="RTL"><strong>لا تأخذ زلديار بشكل أكثر تكرارا مما وصفه لك الطبيب</strong></p><p dir="RTL"><strong>قد يقوم طبيب بزيادة الفواصل الزمنة بين الجرعات في الحالات التالية:</strong></p><p dir="RTL">- إذا كنت أكبر من 75 عام،</p><p dir="RTL">- إذا كنت تعاني من اضطرابات في الكلى.</p><p dir="RTL">- إذا كنت تعاني من اضطرابات في الكبد</p><p dir="RTL">طريقة الاستعمال:</p><p dir="RTL">تؤخذ الأقراص بالفم</p><p dir="RTL">تبلع الأقراص كاملة مع كمية كافية من السوائل، علمًا بأنه يجب عدم كسرها أو مضغها.</p><p dir="RTL">إذا شعرت بأن مفعول الديار كان قوية أكثر مما ينبغي (أي إذا شعرت بالنعاس بشكل قوي أو إذا وجدت صعوبة في التنفس)، أو ضعيفة أكثر من اللازم (أي إذا لم تشعر بتسكين من الألم على نحو كاف) عندها يجب عليك مراجعة طبيبك.</p><p dir="RTL"><strong>إذا أخذت كمية أكبر مما ينبغي من زلديار:</strong></p><p dir="RTL">في هذه الحالات يرجى استشارة الطبيب أو الصيدلاني فورا حتى إذا شعرت بأنك على ما يرام نظرة الإمكانية حدوث خلل في الكبد قد لا يظهر إلا لاحقًا</p><p dir="RTL"><strong>إذا نسيت أخذ زلديار:</strong></p><p dir="RTL">إذا نسيت أحد الأقراص فإنه من المرجح أن يعود الألم في هذه الحال لا تقم بمضاعفة الجرعة لتعويض الجرعات المنفردة التي فاتتك وإنما استمر بأخذ الأقراص كالمعتاد.</p><p dir="RTL"><strong>إذا توقفت عن أخذ زلديار:</strong></p><p dir="RTL">عموما فإن التوقف عن العلاج بمستحضر زلديار لن يترتب عليه حدوث أية تأثيرات أو أعراض لاحقة غير أنه في حالات نادرة فإن الأشخاص الذين كانوا يأخذون ترامادول لبعض الوقت قد يشعرون بالتوعك إذا توقفوا عن العلاج بشكل مفاجئ (انظر فقرة &quot; الأعراض الجانبية الممكن حدوثها&quot;). فإذا كنت تأخذ زلديار البعض الوقت يتوجب عليك استشارة طبيبك إذا رغبت في التوقف عنه نظرا لأنه من الممكن أن يكون جسمك قد تعود عليه.</p><p dir="RTL">يجب عدم التوقف بشكل مفاجئ عن تناول هذا الدواء ما لم يكن ذلك بناء على أمر الطبيب. فإذا أردت التوقف عن تناول الدواء، ناقش الأمر مع طبيبك أولا، وخاصة إذا كنت بدأت تناوله منذ فترة طويلة. سوف يخبرك الطبيب بسبب وكيفية التوقف عن تناول الدواء، ويمكن أن يتم ذلك من خلال خفض الجرعة بالتدريج للحد من الآثار الجانبية المصاحبة (أعراض الانسحاب).</p><p dir="RTL">للمزيد من الأسئلة والاستفسارات حول استعمال هذا المنتج يرجى استشارة الطبيب أو الصيدلاني.</p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">إن هذا الدواء</p><p dir="RTL">- الدواء مستحضر يؤثر على صحتك واستهلاكه خلافا للتعليمات يعرضك للخطر</p><p dir="RTL">- اتبع بدقة وصفة الطبيب وطريقة الاستعمال المنصوص عليها وتعليمات الصيدلاني الذي صرفها لك</p><p dir="RTL">- إلى الطبيب والصيدلاني هما الخبيران بالدواء وينفعه وضرره.</p><p dir="RTL">- لا تقطع مدة العلاج المحددة لك من تلقاء نفسك.</p><p dir="RTL">- لا تكرر صرف الدواء بدون وصفة طبية.</p><p dir="RTL">- لا تترك الأدوية في متناول أيدي الأطفال.</p><p dir="RTL">مجلس وزراء الصحة العرب</p><p dir="RTL">واتحاد الصيادلة العرب</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال مع جميع الأدوية فإن زلديار قد يكون له أعراض جانبية، غير أنها لا تحدث مع جميع المرضى</p><p dir="RTL"><strong><u>أعراض شائعة جدًا </u></strong>أكثر من شخص واحد من بين 10 أشخاص معالجين</p><p dir="RTL">- غثيان.</p><p dir="RTL">- دوار، نعاس</p><p dir="RTL"><strong><u>أعراض شائعة: </u></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقل من شخص واحد من بين 10 أشخاص، ولكن أكثر من شخص واحد من بين ۱۰۰ شخص معالج</p><p dir="RTL">- تقيؤ واضطرابات هضمية (إمساك. انتفاخ البطن، إسهال)، ألم في المعدة، جفاف الفم.</p><p dir="RTL">- حكة، تعرف - الصداع، ارتعاش</p><p dir="RTL">- ارتباك، اضطرابات في النوم، تغيرات في المزاج أقلق، عصبية، ابتهاج ).</p><p dir="RTL"><strong><u>أعراض غير شائعة:</u></strong><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong>أقل من شخص واحد من بين ۱۰۰ شخص، ولكن أكثر من شخص واحد من بين ۱۰۰۰ شخص معالج</p><p dir="RTL"><strong><u>-</u></strong> زيادة في النبض أو ارتفاع ضغط الدم، اضطرابات في سرعة ضربات القلب أو النظم القلبي</p><p dir="RTL">- صعوبة أو ألم عند التبول،</p><p dir="RTL">- تفاعلات جلدية (مثل الطفح أو الشرى)</p><p dir="RTL">- الوخز أو إحساس بالتنمل في الأطراف، طنين الأذنين، انتفاضات عضلية لا إرادية</p><p dir="RTL">- اكتئاب، كوابيس، هلوسة (أي سماع أو رؤية أو شعور شيء ليس له وجود في الحقيقة)، فجوات في الذاكرة .</p><p dir="RTL">- صعوبة في البلع، دم في البراز</p><p dir="RTL">- قشعريرة، هبات سخونة، ألم في الصدر</p><p dir="RTL">- صعوبة في التنفس.</p><p dir="RTL"><strong><u>أعراض نادرة:</u></strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقل من شخص واحد من بين ۱۰۰۰ شخص، ولكن أكثر من شخص واحد من بين ۱۰۰۰۰ شخص معالج</p><p dir="RTL">- نوبات، صعوبات في التنسيق الحركي</p><p dir="RTL">- الإدمان</p><p dir="RTL">- رؤية غير واضحة</p><p dir="RTL">فيما يلي يتم ذكر الأعراض الجانبية التي وردت عن أشخاص استعملوا أدوية تحتوي إما فقط على ترامادول أو فقط على باراسيتامول. غير أنه ينبغي عليك إعلام طبيبك إذا أصابك أي منها أثناء أخذ زلديار:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شعور بالضعف عند القيام بعد الاستلقاء أو الجلوس، بطء في سرعة ضربات القلب، إغماء، تغيرات في الشهية ضعف عضلي، تنفس أبطأ أو أضعف، تغيرات في المزاج تغيرات في النشاط، تغيرات في الإدراك، حدوث تدهور في الربو إن وجد.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; في بعض الحالات النادرة قد يتطور طفح جلدي، مما يشير إلى وجود تفاعل أرجی، مع انتفاخ مفاجئ في الوجه</p><p dir="RTL">والعنق، أو صعوبة في التنفس، أو هبوط في ضغط الدم أو إغماء. في حال حدوث ذلك <u>توقف عن العلاج واستشر الطبيب فورًا. لا يجوز أن تأخذ الدواء ثانية</u></p><p dir="RTL">في حالات نادرة يؤدي استعمال دواء من نوع ترامادول إلى أن تصبح معتمدة عليه مما يجعل الأمر صعبا عليك | في التوقف عن أخذه</p><p dir="RTL">في حالات نادرة قد يشعر الأشخاص الذين أخذوا ترامادول لبعض الوقت بالتوعك عند التوقف عن العلاج فجأة . فقد يشعرون بالهياج، أو القلق، أو العصبية، أو الارتجاف. وقد يشعرون بفرط النشاط، أو يعانون من صعوبة في النوم، أو اضطرابات في المعدة أو الأمعاء، وعدد بسيط جدا من الأشخاص قد يصاب بنوبات ذعر، أو هلوسة، أو إحساس غير طبیعی مثل الحكة والوخز والتنمل، أو رنين في الأذنين (طنين الأذنين)، فإذا أصبت بأي من هذه الأعراض بعد التوقف عن الديار يرجى استشارة طبيبك.</p><p dir="RTL">في حالات استثنائية قد تظهر فحوصات الدم بعض الشواذ المعينة مثل قلة الصفيحات الدموية مما قد يؤدي إلى نزيف أنفي أو نزيف في اللثة.</p><p dir="RTL">إن استعمال زلديار في نفس وقت أخذ الأدوية المستعملة التمييع الدم (على غرار فينوروكومون أو وارفاین) قد يزيد من مخاطر حدوث النزيف، ولذلك فإنه عند حدوث أي نزيف طويل أو غير متوقع يجب عليك إبلاغ طبيبك على الفور</p><p dir="RTL">إذا أصبح أي من الأعراض الجانبية خطيرة أو إذا لاحظت أية أعراض جانبية غير مذكورة في هذه النشرة، عندها يرجى إعلام الطبيب أو الصيدلاني.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ المستحضر بعيدة عن متناول أيدي الأطفال وأنظارهم</p><p dir="RTL">لا تستعمل زلديار بعد تاريخ انتهاء الصلاحية المطبوع على الكرتون وعلى حافة الصفيحة بعد &quot;EXP&quot; بشير تاريخ الانتهاء إلى آخر يوم من ذلك الشهر.</p><p dir="RTL">لا تحفظ الدواء بدرجة حرارة تزيد على ۳۰ م.</p><p dir="RTL">ينبغي عدم التخلص من الأدوية عن طريق إلقائها في مياه الصرف أو النفايات المنزلية برجي الاستفسار لدى الصيدلاني عن كيفية إمكانية طرح الأدوية التي لم تعد بحاجة إليها ستساعدك هذه الإجراءات على حماية البيئة والحفاظ عليها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ما يحتوي عليه زلديار</p><p dir="RTL">- إن المواد الفعالة هي هيدروكلوريد الترامادول وباراسيتامول</p><p dir="RTL">يحتوي كل قرص مغلف على :۳۷,۵ ملغم هيدروكلوريد الترامادول و۳۲۵ ملغم باراسيتامول</p><p dir="RTL">- العناصر الأخرى هي:</p><p dir="RTL"><u>نواة القرص:</u> مسحوق السليولوز نشاء مسبق التهلم، صوديوم نشاء غليكولات (نوع أ)، نشاء الذرة، ستیارات المغنيسيوم.</p><p dir="RTL"><u>طبقة التغليف:</u> هیبرومیلوز، لاكتوز مونوهیدرات، ثاني أكسيد التيتانيوم (إي ۱۷۱)، ماکروجول ۹۰۰۰، اکسید الحديد الأصفر (إي ۱۷۲) غليكول البروبيلين تالك</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إن أقراص زلديار المغلفة لونها أصفر شاحب، و هي مزودة على أحد الوجهين بشعار الشركة، و الوجه الأخر عليه عبارة &quot;5&rdquo;T</p><p dir="RTL">يأتي زلديار في كراتين تحتوي على 10 أقراص أو ۲۰ قرصا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ستادا أرزنیمینال اج</p><p dir="RTL">ستادا شتراسية 2-18</p><p dir="RTL">61118 باد فیلبل</p><p dir="RTL">ألمانيا</p><p dir="RTL">المصنع : بلك:</p><p dir="RTL">فارماسيوتي فورمنتي</p><p dir="RTL">فيا دي فيتوريو ۲</p><p dir="RTL">۳۱۰۰ اوریجیو</p><p dir="RTL">إيطاليا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تاريخ آخر مراجعة: مارس ۲۰۱۸                            
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                zaldiar 37.5 mg/325 mg, film coated-tablets 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                One film-coated tablet contains 37.5 mg tramadol hydrochloride and 325 mg paracetamol Excipients: One film coated tablet contains 1.878 mg lactose monohydrate (= 1.784 mg lactose). For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablet
Pale yellow film-coated tablet, marked with the manufacturer‘s logo on one side and ‘T5’ on the other side.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>zaldiar&nbsp;tablets are indicated for the symptomatic treatment of moderate to severe pain.</p><p>&nbsp;</p><p>The use of &lt;Trademark&gt; should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol (see also Section 5.1).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Posology</em></p><p><em>&nbsp;</em></p><p>The use of zaldiar&nbsp;should be restricted to patients whose moderate to severe pain is considered to require a combination of tramadol and paracetamol.</p><p>&nbsp;</p><p>The dose should be adjusted to intensity of pain and the sensitivity of the individual patient. The lowest effective dose for analgesia should generally be selected. The total dose of 8 tablets (equivalent to 300 mg tramadol hydrochloride and 2600 mg paracetamol) per day should not be exceeded. The dosing interval should not be less than six hours.</p><p>&nbsp;</p><p><u>Adults and adolescents</u> (12 years and older)</p><p>An initial dose of two tablets of zaldiar&nbsp;is recommended Additional doses can be taken as needed, not exceeding 8 tablets (equivalent to 300 mg tramadol and 2600 mg paracetamol) per day.</p><p>The dosing interval should not be less than six hours.</p><p>&nbsp;</p><p>zaldiar&nbsp;should under no circumstances be administered for longer than is strictly necessary (see also section 4.4 - Special warnings and precautions for use). If repeated use or</p><p>&nbsp;</p><p>long term treatment with zaldiar&nbsp;is required as a result of the nature and severity of the illness, then careful, regular monitoring should take place (with breaks in the treatment, where possible), to assess whether continuation of the treatment is necessary.</p><p>&nbsp;</p><p><u>Paediatric population</u></p><p>&nbsp;</p><p>The effective and safe use of&nbsp;zaldiar has not been established in children below the age of 12 years. Treatment is therefore not recommended in this population.</p><p>&nbsp;</p><p><u>Older people</u></p><p>&nbsp;</p><p>A dose adjustment is not usually necessary in patients up to 75 years without clinically manifest hepatic or renal insufficiency. In elderly patients over 75 years elimination may be prolonged. Therefore, if necessary the dosage interval is to be extended according to the patient&#39;s requirements.</p><p>&nbsp;</p><p><u>Renal insufficiency/dialysis</u></p><p>&nbsp;</p><p>In patients with renal insufficiency the elimination of tramadol is delayed. In these patients prolongation of the dosage intervals should be carefully considered according to the patient&#39;s requirements.</p><p>&nbsp;</p><p><u>Hepatic impairment</u></p><p>&nbsp;</p><p>In patients with hepatic impairment the elimination of tramadol is delayed. In these patients prolongation of the dosage intervals should be carefully considered according to the patient&rsquo;s requirements (see section 4.4). Because of the presence of paracetamol &lt;Tradename&gt; should not be used in patients with severe hepatic impairment <u>(see Section 4.3).</u></p><p>&nbsp;</p><p><em>Method</em><em> </em><em>of</em><em> </em><em>administration</em></p><p><em>&nbsp;</em></p><p>Oral use</p><p>&nbsp;</p><p>Tablets must be swallowed whole, with a sufficient quantity of liquid. They must not be broken or chewed.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                -	Hypersensitivity to the active substances or to any of the excipients listed in section 6.1
-	acute intoxication with alcohol, hypnotic drugs, centrally-acting analgesics, opioids or psychotropic drugs,
-	zaldiar should not be administered to patients who are receiving monoamine oxidase inhibitors or within two weeks of their withdrawal (see 4.5. Interactions with other medicinal products and other forms of interaction),
-	severe hepatic impairment,
-	epilepsy not controlled by treatment (see. 4.4. Special Warnings).

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Warnings:</em></p><p><em>&nbsp;</em></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In adults and adolescents 12 years and older. The maximum dose of 8 tablets of</p><p>zaldiar&nbsp;should not be exceeded. In order to avoid inadvertent overdose, patients should be advised not to exceed the recommended dose and not to use any other paracetamol (including over the counter) or tramadol hydrochloride containing products concurrently without the advice of a physician.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In severe renal insufficiency (creatinine clearance &lt;10 ml/mm), zaldiar&nbsp;is not recommended.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In patients with severe hepatic impairment zaldiar&nbsp;should not be used (See Section 4.3). The hazards of paracetamol overdose are greater in patients with non-cirrhotic alcoholic liver disease. In moderate cases prolongation of dosage interval should be carefully considered.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In severe respiratory insufficiency, zaldiar&nbsp;is not recommended.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tramadol is not suitable as a substitute in opioid-dependent patients. Although it is an opioid agonist, tramadol cannot suppress morphine withdrawal symptoms.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Convulsions have been reported in tramadol-treated patients susceptible to seizures or taking other medications that lower the seizure threshold, especially selective serotonin re- uptake inhibitors, tricyclic antidepressants, antipsychotics, centrally acting analgesics or local anaesthesia. Epileptic patients controlled by a treatment or patients susceptible to seizures should be treated with zaldiar&nbsp;only if there are compelling circumstances. Convulsions have been reported in patients receiving tramadol at the recommended dose levels. The risk may be increased when doses of tramadol exceed the recommended upper dose limit</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Concomitant use of opioid agonists-antagonists (nalbuphine, buprenorphine, pentazocine) is not recommended (see section 4.5).</p><p>&nbsp;</p><p><em>Precautions for use</em></p><p><em>&nbsp;</em></p><p>Tolerance and physical and/or psychological dependence may develop, even at therapeutic doses. The clinical need for analgesic treatment should be reviewed regularly (see 4.2). In opioid-dependent patients and patients with a history of drug abuse or dependence, treatment should only be for short period and under medical supervision. zaldiar&nbsp;should be used with caution in patients with cranial trauma, in patients prone to convulsive disorder, biliary tract disorders, in a state of shock, in an altered state of consciousness for unknown reasons, with problems affecting the respiratory center or the respiratory function, or with an increased intracranial pressure.</p><p>&nbsp;</p><p>Paracetamol in overdose may cause hepatic toxicity in some patients.</p><p>&nbsp;</p><p>Symptoms of withdrawal reaction, similar to those occurring during opiate withdrawal, may occur even at therapeutic doses and for short term treatment (see section 4.8). Withdrawal symptoms may be avoided by taper it at the time of discontinuation especially after long treatment periods. Rarely, cases of dependence and abuse have been reported (see section 4.8).</p><p>&nbsp;</p><p>&nbsp;</p><p>In one study, use of tramadol during general anaesthesia with enflurane and nitrous oxide was reported to enhance intra-operative recall. Until further information is available, use of tramadol during light planes of anaesthesia should be avoided.</p><p>&nbsp;</p><p>zaldiar&nbsp;tablets contain lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Concomitant use is contraindicated with:</em></p><p><em>&nbsp;</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-selective MAO Inhibitors</p><p>Risk of serotonergic syndrome: diarrhoea, tachycardia, hyperhidrosis, trembling, confusional state, even coma.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Selective-A MAO Inhibitors</p><p>Extrapolation from non-selective MAO inhibitors</p><p>Risk of serotonergic syndrome: diarrhoea, tachycardia, hyperhidrosis, trembling, confusional state, even coma.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Selective-B MAO Inhibitors</p><p>Central excitation symptoms evocative of a serotonergic syndrome: diarrhoea, tachycardia, hyperhidrosis, trembling, confusional state, even coma<strong>.</strong></p><p><strong>&nbsp;</strong></p><p>In case of recent treatment with MAO inhibitors, a delay of two weeks should occur before treatment with tramadol</p><p>&nbsp;</p><p><em>Concomitant use is not recommended with:</em></p><p><em>&nbsp;</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Alcohol</p><p>Alcohol increases the sedative effect of opioid analgesics.</p><p>The effect on alertness can make driving of vehicles and the use of machines dangerous. Avoid intake of alcoholic drinks and of medicinal products containing alcohol.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Carbamazepine and other enzyme inducers</p><p>Risk of reduced efficacy and shorter duration due to decreased plasma concentrations of tramadol.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Opioid agonists-antagonists (buprenorphine, nalbuphine, pentazocine)</p><p>Decrease of the analgesic effect by competitive blocking effect at the receptors, with the risk of occurrence of withdrawal syndrome.</p><p>&nbsp;</p><p><em>Concomitant use which needs to be taken into consideration:</em></p><p><em>&nbsp;</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tramadol can induce convulsions and increase the potential for selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants, antipsychotics and seizure threshold-lowering medicinal products (such as bupropion, mirtazapine, tetrahydrocannabinol) to cause convulsions.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; Concomitant therapeutic use of tramadol and serotonergic drugs such as selective serotonin re-uptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), MAO inhibitors (see section 4.3), tricyclic antidepressants and mirtazapine may cause serotonin toxicity. Serotonin syndrome is likely when one of the following is observed:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Spontaneous clonus</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inducible or ocular clonus with agitation or diaphoresis ,</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tremor and hyperreflexia</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypertonia and body temperature &gt; 38 &deg;C and inducible or ocular clonus.</p><p>Withdrawal of the serotonergic drugs usually brings about a rapid improvement. Treatment depends on the type and severity of the symptoms.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other opioid derivatives (including antitussive drugs and substitutive treatments), benzodiazepines and barbiturates</p><p>Increased risk of respiratory depression which can be fatal in cases of overdose.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other central nervous system depressants, such as other opioid derivatives (including antitussive drugs and substitutive treatments), barbiturates, benzodiazepines, other anxiolytics, hypnotics, sedative antidepressants, sedative antihistamines, neuroleptics, centrally-acting antihypertensive drugs, thalidomide and baclofen.</p><p>These drugs can cause increased central depression. The effect on alertness can make driving of vehicles and the use of machines dangerous.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp; As medically appropriate, periodic evaluation of prothrombin time should be performed when zaldiar&nbsp;and warfarin like compounds are administered concurrently due to reports of increased INR.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In a limited number of studies the pre- or postoperative application of the antiemetic 5- HT3 antagonist ondansetron increased the requirement of tramadol in patients with postoperative pain.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Pregnancy</em></p><p><em>&nbsp;</em></p><p><u>Since zaldiar&nbsp;is a fixed combination of active ingredients including tramadol, it should</u> <u>not be used during pregnancy.</u></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Data regarding paracetamol:</p><p>&nbsp;</p><p>Epidemiological studies in human pregnancy have shown no ill effects due to paracetamol used in the recommended dosages.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Data regarding tramadol:</p><p>Tramadol should not be used during pregnancy as there is inadequate evidence available to assess the safety of tramadol in pregnant women. Tramadol administered before or during birth does not affect uterine contractility. In neonates it may induce changes in the respiratory rate which are usually not clinically relevant. Long-term treatment during pregnancy may lead to withdrawal symptoms in the newborn after birth, as a consequence of habituation.</p><p>&nbsp;</p><p><em>Breast-feeding:</em></p><p><em>&nbsp;</em></p><p>Since zaldiar&nbsp;is a fixed combination of active ingredients including tramadol, it should not be ingested during breast feeding.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Data regarding paracetamol:</p><p>Paracetamol is excreted in breast milk&nbsp; but&nbsp; not&nbsp; in&nbsp; a&nbsp; clinically&nbsp; significant&nbsp; amount. Available published data do not contraindicate breast feeding by women using single ingredient medicinal products containing only paracetamol.</p><p>&nbsp;</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Data regarding tramadol:</p><p>Approximately 0.1% of the maternal dose of tramadol is excreted in breast milk. In the immediate post-partum period, for maternal oral daily dosage up to 400 mg, this corresponds to a mean amount of tramadol ingested by breast-fed infants of 3% of the maternal weight- adjusted dosage. For this reason tramadol should not be used during lactation or alternatively, breast-feeding should be discontinued during treatment with tramadol. Discontinuation of breast-feeding is generally not necessary following a single dose of tramadol.</p><p>&nbsp;</p><p><em>Fertility</em></p><p><em>&nbsp;</em></p><p>Post marketing surveillance does not suggest an effect of tramadol on fertility.</p><p>Animal studies did not show an effect of tramadol on fertility. No study on fertility was accomplished with the combination of tramadol and paracetamol</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tramadol may cause drowsiness or dizziness, which may be enhanced by alcohol or other CNS depressants. If affected, the patient should not drive or operate machinery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported undesirable effects during the clinical trials performed with the paracetamol/tramadol hydrochloride combination were nausea, dizziness and somnolence, observed in more than 10 % of the patients.</p><p>&nbsp;</p><p>The frequencies are defined as follows:</p><p>Very common:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &ge;1/10</p><p>Common:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &ge;1/100 to &lt;1/10</p><p>Uncommon:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&ge;1/1000 to &lt;1/100</p><p>Rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &ge;1/10 000 to &lt;1/1000</p><p>Very rare:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&lt;1/10 000</p><p>Unknown:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Frequency cannot be estimated from the available data</p><p>&nbsp;</p><p>Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><p><em>Cardiac</em><em> </em><em>disorders:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: palpitations, tachycardia, arrythmia.</p><p><em>Eye disorders:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare: vision blurred, miosis, mydriasis.</p><p><em>Ear and labyrinth disorders:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: tinnitus.</p><p><em>Gastro-intestinal</em><em> </em><em>disorders:&nbsp;</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very common: nausea</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common: vomiting, constipation, dry mouth, diarrhoea abdominal pain, dyspepsia, flatulence</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: dysphagia, melaena.</p><p>&nbsp;</p><p><em>General disorders and administration site conditions:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: chills, chest pain.</p><p><em>Investigations:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: transaminases increased.</p><p><em>Metabolism and nutrition disorders:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unknown: hypoglycaemia.</p><p><em>Nervous system disorders:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very common: dizziness, somnolence</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common: headache trembling</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: muscle contractions involuntary, paraesthesia, amnesia</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare: ataxia, convulsions, syncope, speech disorders.</p><p>&nbsp;</p><p><em>Psychiatric</em><em> </em><em>disorders:</em></p><p><em>&nbsp;</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common: confusional state, mood altered, anxiety, nervousness, euphoric mood, sleep disorders</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: depression, hallucinations, nightmares</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare: delirium, drug dependence.</p><p>&nbsp;</p><p><u>Post marketing surveillance</u> Very rare: abuse.</p><p><em>Renal and urinary disorders:</em></p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: albuminuria, micturition disorders (dysuria and urinary retention).</p><p><em>Respiratory,</em><em> </em><em>thoracic</em><em> </em><em>and</em><em> </em><em>mediastinal disorders:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: dyspnoea.</p><p><em>Skin</em><em> </em><em>and</em><em> </em><em>subcutaneous</em><em> </em><em>tissue disorders:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common: hyperhidrosis, pruritus</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: dermal reactions (e.g. rash, urticaria).</p><p><em>Vascular</em><em> </em><em>disorders:</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Uncommon: hypertension, hot flush.</p><p>Although not observed during clinical trials, the occurrence of the following undesirable effects known to be related to the administration of tramadol or paracetamol cannot be excluded:</p><p>&nbsp;</p><p><strong><u>Tramadol</u></strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Postural hypotension, bradycardia, collapse (tramadol).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Post-marketing surveillance of tramadol has revealed rare alterations of warfarin effect, including elevation of prothrombin times.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare cases (&ge; 1/10000 to &lt; 1/1000) : allergic reactions with respiratory symptoms (e.g. dyspnoea, bronchospasm, wheezing, angioneurotic oedema) and anaphylaxis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare cases (&ge; 1/10000 to &lt; 1/1000) : changes in appetite, motor weakness, and respiratory depression</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Psychic side-effects may occur following administration of tramadol which vary individually in intensity and nature (depending on personality and duration of medication). These include changes in mood, (usually euphoric mood occasionally dysphoria), changes in activity (usually suppression occasionally increase) and changes in cognitive and sensorial capacity (e.g. decision behaviour perception disorders).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Worsening of asthma has been reported though a causal relationship has not been established.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Symptoms of drug withdrawal syndrome, similar to those occurring during opiate withdrawal may occur as follows: agitation, anxiety, nervousness, insomnia, hyperkinesia, tremor and gastrointestinal symptoms. Other symptoms that have very rarely been seen if tramadol hydrochloride is discontinued abruptly include: panic attacks, severe anxiety, hallucinations, paraesthesia, tinnitus and unusual CNS symptoms.</p><p>&nbsp;</p><p><strong><u>Paracetamol</u></strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Adverse effects of paracetamol are rare but hypersensitivity including skin rash may occur. There have been reports of blood dyscrasias including thrombocytopenia and agranulocytosis, but these were not necessarily causally related to paracetamol.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There have been several reports that suggest that paracetamol may produce hypoprothrombinemia when administered with warfarin-like compounds. In other studies, prothrombin time did not change.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Very rare cases of serious skin reactions have been reported.</p><p>&nbsp;</p><p><em>Reporting of suspected adverse reactions</em></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via &lt;[to be completed nationally]&gt;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>zaldiar is a fixed combination of active ingredients. In case of overdose, the symptoms may include the signs and symptoms of toxicity of tramadol or paracetamol or of both these active ingredients.</p><p>&nbsp;</p><p><em>Symptoms of overdose from tramadol:</em></p><p><em>&nbsp;</em></p><p>In principle, on intoxication with tramadol, symptoms similar to those of other centrally acting analgesics (opioids) are to be expected. These include in particular, miosis, vomiting, cardiovascular collapse, consciousness disorders up to coma, convulsions and respiratory depression up to respiratory arrest.</p><p>&nbsp;</p><p><em>Symptoms of overdose from paracetamol:</em></p><p>An overdose is of particular concern in young children. Symptoms of paracetamol overdosage in the first 24 hours are pallor, nausea, vomiting, anorexia and abdominal pain. Liver damage may become apparent 12 to 48 hours after ingestion. Abnormalities of glucose metabolism and metabolic acidosis may occur. In severe poisoning, hepatic failure may progress to encephalophathy, coma and death. Acute renal failure with acute tubular necrosis may develop even in the absence of severe liver damage. Cardiac arrhythmias and pancreatitis have been reported.</p><p>&nbsp;</p><p>Liver damage is possible in adults who have taken 7.5-10 g or more of paracetamol. It is considered that excess quantities of a toxic metabolite (usually adequately detoxified by glutathione when normal doses of paracetamol are ingested), become irreversibly bound to liver tissue.</p><p>&nbsp;</p><p><u>Emergency treatment:</u></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfer immediately to a specialised unit.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Maintain respiratory and circulatory functions</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Prior to starting treatment, a blood sample should be taken as soon as possible after overdose in order to measure the plasma concentration of paracetamol and tramadol and in order to perform hepatic tests.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Perform hepatic tests at the start (of overdose) and repeat every 24 hours. An increase in hepatic enzymes (ASAT, ALAT) is usually observed, which normalizes after one or two weeks.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Empty the stomach by causing the patient to vomit (when the patient is conscious) by irritation or gastric lavage.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Supportive measures such as maintaining the patency of the airway and maintaining cardiovascular function should be instituted; naloxone should be used to reverse respiratory depression; fits can be controlled with diazepam.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tramadol is minimally eliminated from the serum by haemodialysis or haemofiltration.</p><p>Therefore treatment of acute intoxication with zaldiar with haemodialysis or haemofiltration alone is not suitable for detoxification.</p><p>&nbsp;</p><p>Immediate treatment is essential in the management of paracetamol overdose. Despite a lack of significant early symptoms, patients should be referred to hospital urgently for immediate medical attention and any adult or adolescent who had ingested around 7.5 g or more of paracetamol in the preceding 4 hours or any child who has ingested &sup3;150 mg/kg of paracetamol in the preceding 4 hours should undergo gastric lavage. Paracetamol</p><p>&nbsp;</p><p>concentrations in blood should be measured later than 4 hours after overdose in order to be able to assess the risk of developing liver damage (via the paracetamol overdose nomogram). Administration of oral methionine or intravenous N-acetylcysteine (NAC) which may have a beneficial effect up to at least 48 hours after the overdose, may be required. Administration of intravenous NAC is most beneficial when initiated within 8 hours of overdose ingestion.</p><p>However, NAC should still be given if the time to presentation is greater than 8 hours after overdose and continued for a full course of therapy. NAC treatment should be started immediately when massive overdose is suspected. General supportive measures must be available.</p><p>&nbsp;</p><p>Irrespective of the reported quantity of paracetamol ingested, the antidote for paracetamol, NAC, should be administered orally or intravenously, as quickly as possible, if possible, within 8 hours following the overdose.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Other opioids Tramadol, combinations ATC code: N02A X 52</p><p>&nbsp;</p><p>ANALGESICS</p><p>Tramadol is an opioid analgesic that acts on the central nervous system. Tramadol is a pure non selective agonists of the m, d, and k opioid receptors with a higher affinity for the &micro; receptors. Other mechanisms which contribute to its analgesic effect are inhibition of neuronal reuptake of noradrenaline and enhancement of serotonin release. Tramadol has an antitussive effect. Unlike morphine, a broad range of analgesic doses of tramadol has no respiratory depressant effect.</p><p>Similarly, the gastro-intestinal motility is not modified. The cardiovascular effects are generally slight. The potency of tramadol is considered to be one-tenth to one-sixth that of morphine.</p><p>&nbsp;</p><p>The precise mechanism of the analgesic properties of paracetamol is unknown and may involve central and peripheral effects.</p><p>&nbsp;</p><p>zaldiar is positioned as a step II analgesic in the WHO pain ladder and should be utilised accordingly by the physician.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tramadol is administered in racemic form and the [-] and [+] forms of tramadol and its metabolite M1, are detected in the blood. Although tramadol is rapidly absorbed after administration, its absorption is slower (and its half-life longer) than that of paracetamol.</p><p>&nbsp;</p><p>After a single oral administration of a tramadol/paracetamol (37.5 mg/325 mg) tablet, peak plasma concentrations of 64.3/55.5 ng/ml [(+)-tramadol/(-)-tramadol] and 4.2 &micro;g/ml (paracetamol) are reached after 1.8 h [(+)-tramadol/(-)-tramadol] and 0.9 h (paracetamol) respectively. The mean elimination half-lives t1/2 are</p><p>5.1/4.7 h [(+)-tramadol/(-)-tramadol] and 2,5 h (paracetamol).</p><p>&nbsp;</p><p>During pharmacokinetic studies in healthy volunteers after single and repeated oral administration of zaldiar, no clinical significant change was observed in the kinetic parameters of each active ingredient compared to the parameters of the active ingredients used alone.</p><p>&nbsp;</p><p>&nbsp;</p><p><em>Absorption:</em></p><p>Racemic tramadol is rapidly and almost completely absorbed after oral administration. The mean absolute bioavailability of a single 100 mg dose is approximately 75 %. After repeated administration, the bioavailability is increased and reaches approximately 90 %.</p><p>After administration of zaldiar&nbsp;, the oral absorption of paracetamol is rapid and nearly complete and takes place mainly in the small intestine. Peak plasma concentrations of paracetamol are reached in one hour and are not modified by concomitant administration of tramadol.</p><p>The oral administration of zaldiar&nbsp;with food has no significant effect on the peak plasma concentration or extent of absorption of either tramadol or paracetamol so that &lt;Trademark&gt; can be taken independently of meal times.</p><p>&nbsp;</p><p><em>Distribution:</em></p><p>Tramadol has a high tissue affinity (Vd,b=203 &plusmn;&nbsp;40 l). It has a plasma protein binding of about 20%.</p><p>Paracetamol appears to be widely distributed throughout most body tissues except fat. Its apparent volume of distribution is about 0.9 l/kg. A relative small portion (~20%) of paracetamol is bound to plasma proteins.</p><p>&nbsp;</p><p><em>Metabolism:</em></p><p>Tramadol is extensively metabolized after oral administration. About 30 % of the dose is excreted in urine as unchanged drug, whereas 60% of the dose is excreted as metabolites.</p><p>&nbsp;</p><p>Tramadol is metabolised through O-demethylation (catalysed by the enzyme CYP2D6) to the metabolite M1, and through <em>N</em>-demethylation (catalysed by CYP3A) to the metabolite M2. M1 is further metabolised through N-demethylation and by conjugation with glucuronic acid. The plasma elimination half-life of M1 is 7 hours. The metabolite M1 has analgesic properties and is more potent than the parent drug. The plasma concentrations of M1 are several-fold lower than those of tramadol and the contribution to the clinical effect is unlikely to change on multiple dosing.</p><p>&nbsp;</p><p>Paracetamol is principally metabolized in the liver through two major hepatic routes: glucuronidation and sulphation. The latter route can be rapidly saturated at doses above the therapeutic doses. A small fraction (less than 4%) is metabolized by cytochrome P 450 to an active intermediate (the N-acetyl benzoquinoneimine) which, under normal conditions of use, is rapidly detoxified by reduced glutathione and excreted in urine after conjugation to cysteine and mercapturic acid. However, during massive overdose, the quantity of this metabolite is increased.</p><p>&nbsp;</p><p><em>Elimination:</em></p><p>Tramadol and its metabolites are eliminated mainly by the kidneys. The half-life of paracetamol is approximately 2 to 3 hours in adults. It is shorter in children and slightly longer in the newborn and in cirrhotic patients. Paracetamol is mainly eliminated by dose-dependent formation of glucuro- and sulpho-conjugate derivatives. Less than 9 % of paracetamol is excreted unchanged in urine. In renal insufficiency, the half-life of both compounds is prolonged.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No preclinical study has been performed with the fixed combination (tramadol and paracetamol) to evaluate its carcinogenic or mutagenic effects or its effects on fertility.</p><p>No teratogenic effect that can be attributed to the medicine has been observed in the progeny of rats treated orally with the combination tramadol/paracetamol.</p><p>The combination tramadol/paracetamol has proven to be embryotoxic and foetotoxic in the rat at materno-toxic dose (50/434 mg/kg tramadol/paracetamol), i.e., 8.3 times the maximum therapeutic dose in man. No teratogenic effect has been observed at this dose. The toxicity to the embryo and the foetus results in a decreased foetal weight and an increase in supernumerary ribs. Lower doses, causing less severe materno-toxic effect (10/87 and 25/217 mg/kg tramadol/paracetamol) did not result in toxic effects in the embryo or the foetus.</p><p>Results of standard mutagenicity tests did not reveal a potential genotoxic risk for tramadol in man.</p><p>Results of carcinogenicity tests do not suggest a potential risk of tramadol for man.</p><p>Animal studies with tramadol revealed, at very high doses, effects on organ development, ossification and neonatal mortality, associated with maternotoxicity. Fertility reproductive performance and development of offspring were unaffected. Tramadol crosses the placenta. Male and female fertility was not affected.</p><p>Extensive investigations showed no evidence of a relevant genotoxic risk of paracetamol at therapeutic (i.e. non-toxic) doses.</p><p>Long-term studies in rats and mice yielded no evidence of relevant tumorigenic effects at non- hepatotoxic dosages of paracetamol.</p><p>Animal studies and extensive human experience to date yield no evidence of reproductive toxicity.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Tablet core:</u></p><p>powdered cellulose pregelatinised starch</p><p>sodium starch glycolate (Type A) maize starch</p><p>magnesium stearate</p><p>&nbsp;</p><p><u>Film-coating:</u> hypromellose lactose monohydrate</p><p>titanium dioxide (E 171) macrogol 6000</p><p>yellow iron oxide (E 172) propylene glycol</p><p>talc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years in paper/PET/aluminium-PVC blister packs.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product does not require any special storage conditions.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>zaldiar tablets are packed in paper/PET/aluminium-PVC blisters. Box of 2 tablets, of 10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 tablets Not all packaging sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                To be completed nationally.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                To be completed nationally.
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>